Journal article · 2026 · Open access

A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology

Xuxu Zhuang, Jing-Fang Luo, Ziying Wang, Olympia Apokotou, Xinjie Guan, Xiaoxia Peng, Yu Dong, Jiayue Chen, Liming Xie, Chen Ming, Hanming Shen, Evandro Fei Fang and 8 more

Acta Pharmaceutica Sinica B · Published 1 October 2026 · DOI 10.1016/j.apsb.2026.09.026

Open PDFView at the publisherCite this paper

In brief

“A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology” is a 2026 journal article by Xuxu Zhuang and 19 co-authors, published in Acta Pharmaceutica Sinica B. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Acta Pharmaceutica Sinica B.

Citations
0
References
50
Authors
20

Abstract

The emergence of vibe coding, a natural language-driven programming paradigm powered by large language models, is transforming computational biology by enabling researchers without extensive coding expertise to design and execute complex analyses. Leveraging high-throughput imaging integrated with vibe coding workflows, we screened a natural compound library and identified the triterpenoid betulinaldehyde (Betu) as a potent mTOR-independent activator of TFEB. In cross-species Parkinson’s disease (PD) models, including patient-derived dopaminergic neurons, transgenic Drosophila and mice, Betu rescued neurodegeneration and restored lysosomal function and autophagic flux. Mechanistically, Betu induced mild mitochondrial permeability transition pore (mPTP) opening, triggering Ca 2+ efflux that activated calcineurin and promoted TFEB nuclear translocation, thereby enhancing lysosomal biogenesis and function. The anti-aging lipid ceramide, a known inducer of moderate mPTP opening, similarly engaged this mitochondria–lysosome axis, suggesting a general cytoprotective response to cellular stress and aging through mitochondria-to-lysosome communication. Collectively, these findings demonstrate how large language model-assisted vibe coding democratizes computational biology by enabling resource-limited, non-programming scientists to perform high-throughput, reproducible analyses, while identifying a novel mitochondria-to-lysosome signaling cascade (mitochondria–Ca 2+ /calcineurin/TFEB/lysosome biogenesis) as a therapeutic target for PD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhuang, X., Luo, J.-F., Wang, Z., Apokotou, O., Guan, X., Peng, X., Dong, Y., Chen, J., Xie, L., Ming, C., Shen, H., Fang, E. F., Li, M., Su, H., Ye, K., Liu, C., Matsas, R., Papastefanaki, F., Tan, J., & Lu, J. (2026). A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.09.026

MLA 9

Zhuang, Xuxu, et al. “A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology.” Acta Pharmaceutica Sinica B, 2026. https://doi.org/10.1016/j.apsb.2026.09.026.

Chicago

Zhuang, Xuxu, Jing-Fang Luo, Ziying Wang, Olympia Apokotou, Xinjie Guan, Xiaoxia Peng, Yu Dong, et al. 2026. “A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology.” Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.09.026.

Harvard

Zhuang, X. et al. (2026) ‘A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology’, Acta Pharmaceutica Sinica B. doi:10.1016/j.apsb.2026.09.026.

IEEE

X. Zhuang et al., “A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology,” Acta Pharmaceutica Sinica B, 2026, doi: 10.1016/j.apsb.2026.09.026.

BibTeX

@article{zhuang2026high,
  title     = {{A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology}},
  author    = {Zhuang, Xuxu and Luo, Jing-Fang and Wang, Ziying and Apokotou, Olympia and Guan, Xinjie and Peng, Xiaoxia and Dong, Yu and Chen, Jiayue and Xie, Liming and Ming, Chen and Shen, Hanming and Fang, Evandro Fei and Li, Min and Su, Huanxing and Ye, Keqiang and Liu, Chaoyang and Matsas, Rebecca and Papastefanaki, Florentia and Tan, Jieqiong and Lu, Jiahong},
  journal   = {Acta Pharmaceutica Sinica B},
  year      = {2026},
  doi       = {10.1016/j.apsb.2026.09.026},
  url       = {https://doi.org/10.1016/j.apsb.2026.09.026}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy

  • Parkinson's disease
  • TFEB
  • triterpenoids
  • calcineurin
  • lysosomal biogenesis
  • autophagy
  • ceramide
  • dopaminergic neurons

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zhuang, X., Luo, J.-F., Wang, Z., Apokotou, O., Guan, X., Peng, X., Dong, Y., Chen, J., Xie, L., Ming, C., Shen, H., Fang, E. F., Li, M., Su, H., Ye, K., Liu, C., Matsas, R., Papastefanaki, F., Tan, J., & Lu, J. (2026). A high-content screening combined with AI-assisted vibe coding approach identifies a mitochondria-to-lysosome signaling cascade ameliorating Parkinson's pathology. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.09.026

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Acta Pharmaceutica Sinica B: sign in and open the PDF from this page.

Who wrote this paper?

Xuxu Zhuang, Jing-Fang Luo, Ziying Wang, Olympia Apokotou, Xinjie Guan, Xiaoxia Peng, Yu Dong, Jiayue Chen, Liming Xie, Chen Ming, Hanming Shen, Evandro Fei Fang and 8 more.

What is the DOI of this paper?

10.1016/j.apsb.2026.09.026, permanently at https://doi.org/10.1016/j.apsb.2026.09.026. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.